Cataract and Refractive Surgery: Hoping For a Rebound
Article preview reprinted Medtech Insight - May, 2009
April's annual meeting of the American Society of Cataract and Refractive Surgery took place against of the darkest market backdrops in memory. The mood at ASCRS was not all gloom and doom, however. Cataract and refractive surgery technology continues to advance and a number of new product were introduced at the meeting. Find out more...
Article preview reprinted Medtech Insight - May, 2009
Cataract and Refractive Surgery: Hoping For a Rebound
The American Society of Cataract and Refractive Surgery's (ASCRS) 2009 annual symposium took place in April in San Francisco, against one of the darkest market backdrops in memory. Laser vision correction (LVC) procedure volumes declined precipitously in 2008, driven by the impact of the global economic crisis on consumer spending and elective procedures, and more of the same is expected for 2009. The economy has also affected the market for premium intraocular lenses (IOLs), leading to a flat market where there would otherwise be growth. Even the reliable, steady-growth Medicare cataract market has witnessed a rare decline.
Purchase this article online as a PDF and receive it immediately via email. Questions? Call (800) 332-2181. 100% Satisfaction Guaranteed.
Companies mentioned in this article:
Abbott Laboratories Inc.
Medtech Insight delivers the quality content you need on medical technologies impacting the spectrum of surgical, orthopedic, cardiovascular, and other markets. Written and edited by seasoned industry participants and experts, the Medtech Insight newsletter provides insights into the technology and market developments (devices, instrumentation, biomaterials, gene therapy, tissue engineering, etc.) impacting a wide range of surgical and non-surgical clinical practices (cardiothoracic & vascular surgery, general surgery, orthopedics & spine surgery, interventional radiology/cardiology, etc.). Learn more at www.medtechinsight.com.
